TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26625989

Group type: EXPERIMENTAL
Intervention: 1% subcutaneous lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multimodal analgesia regime comprising systemic anti‐inflammatory agents and opioids
Number of subjects: 60
Study: 23263241

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg/day
Number of subjects: 47
Study: 20681960

Group type: EXPERIMENTAL
Intervention: Acute stroke care in stroke units
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Surviving patients
Number of subjects: 687
Study: 19134126

Group type: EXPERIMENTAL
Intervention: 5% sodium ascorbyl phosphate (SAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2% retinol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of 5% SAP and 0.2% retinol
Number of subjects: 0
Study: 16786230

Group type: EXPERIMENTAL
Intervention: Extended-duration thromboprophylaxis with enoxaparin 40 mg subcutaneously once daily for an additional 28 +/- 4 days
Number of subjects: 4726

Group type: COMPARATOR
Intervention: Standard regimen of enoxaparin 40 mg subcutaneously once daily for 10 +/- 4 days
Number of subjects: 4726

Group type: EXPERIMENTAL
Intervention: Extended-duration thromboprophylaxis with enoxaparin
Number of subjects: 4726
Study: 14745143

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 2139

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 2139

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 2139

Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 2139

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 2139

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 2139

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg
Number of subjects: 2139
Study: 11389491

Group type: EXPERIMENTAL
Intervention: Cefoperazone-sulbactam plus cotrimoxazole (cefoperazone 25 mg/kg/day, TMP-SMZ at a ratio of 80:400, TMP 8 mg/kg/day)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Ceftazidime plus cotrimoxazole (ceftazidime 100 mg/kg/day, TMP-SMZ at a ratio of 80:400, TMP 8 mg/kg/day)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 219
Study: 8978577

Group type: EXPERIMENTAL
Intervention: UFT (350 mg/m2/day orally x 14 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 5-FU (500 mg/m2 I.V. days 1 and 8)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 62

Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 62
Study: 8440838

Group type: EXPERIMENTAL
Intervention: Weight Training (WT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall Program Adherence
Number of subjects: 36
Study: 3545719

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 28
Study: 30297569

Group type: EXPERIMENTAL
Intervention: Cowpea fortified cookies (60:40 ratio of cowpea to wheat)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 100% wheat cookies (Control)
Number of subjects: 17
Study: 27554441

Group type: EXPERIMENTAL
Intervention: G5 embryo culture medium
Number of subjects: 836

Group type: COMPARATOR
Intervention: HTF embryo culture medium
Number of subjects: 836
Study: 24519752

Group type: EXPERIMENTAL
Intervention: Intravenous trastuzumab plus chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study: 22360924

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone plus orally administered 17 Beta estradiol
Number of subjects: 12

Group type: COMPARATOR
Intervention: No luteal support
Number of subjects: 12
Study: 20180606

Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 18538237

Group type: EXPERIMENTAL
Intervention: Quad-helix appliance
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Expansion plate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Composite onlay
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 60
Study: 15944337

Group type: COMPARATOR
Intervention: Calcium carbonate (CaCO3), n = 14
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sevelamer, n = 15
Number of subjects: 29
Study: 11827233

Group type: EXPERIMENTAL
Intervention: Työhön Job Search Program
Number of subjects: 1261
Study: 10075388

Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 30

Group type: COMPARATOR
Intervention: healthy control subjects
Number of subjects: 30
Study: 7491693

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Immunosuppressive drugs
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Post-rejection compliance scores
Number of subjects: 127
Study: 2181950

Group type: EXPERIMENTAL
Intervention: Gastrogastrostomy
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Vertical gastroplasty
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 310
Study: 1186568

Group type: EXPERIMENTAL
Intervention: Specific hyposensibilisation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Avoidance measurements
Number of subjects: 160
Study: 31251444

Group type: EXPERIMENTAL
Intervention: BTX 160 U
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BTX 200 U
Number of subjects: 40
Study: 29231497

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding at bilateral Pishu (BL 20), Weiwanxiashu (EX‐B 3), Ganshu (BL 18), Shenshu (BL 23), and Zusanli (ST 36), once every 15 days for 6 times.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group received diabetes health education only.
Number of subjects: 86
Study: 24215741

Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique with critical crest angulation (CA) < 150°
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique with critical crest angulation (CA) > 150°
Number of subjects: 26
Study: 23461841

Group type: EXPERIMENTAL
Intervention: 500 mg glucophage po bid for 12 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 400 mg magnesium oxide po bid for 12 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 50 mg spironolactone po bid for 12 weeks
Number of subjects: 36
Study: 22163272

Group type: EXPERIMENTAL
Intervention: Whole Body Cryotherapy (WBC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Far Infrared (FIR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive (PAS)
Number of subjects: 9
Study: 20155608

Group type: EXPERIMENTAL
Intervention: Four-session motivational intervention
Number of subjects: 277

Group type: COMPARATOR
Intervention: Assessment-only condition
Number of subjects: 277
Study: 16684023

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) antitachycardia pacing (ATP)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Right ventricular (RV) antitachycardia pacing (ATP)
Number of subjects: 400
Study: 15230484

Group type: EXPERIMENTAL
Intervention: 10 mg AT-1015 BID
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: 20 mg AT-1015 BID
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: 40 mg AT-1015 BID
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study: 11312478

Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in prone position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in right lateral decubitus position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in left lateral decubitus position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transesophageal atrial pacing supine
Number of subjects: 30
Study: 9386849

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (n = 21)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) (n = 8)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal volunteers (control group, n = 14)
Number of subjects: 29
Study: 7970064

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (parnaparin)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Calcium heparin
Number of subjects: 160
Study: 3299090

Group type: EXPERIMENTAL
Intervention: Oral azidothymidine (AZT)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 29746726

Group type: EXPERIMENTAL
Intervention: Generic candesartan 16 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Branded formulation
Number of subjects: 42
Study: 27585757

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy (aiming for revascularisation within 7 days)
Number of subjects: 2457

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy
Number of subjects: 2457
Study: 25686142

Group type: EXPERIMENTAL
Intervention: Enhanced arm (previous substance-using HIV/AIDS outreach workers)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard arm (CDPH personnel)
Number of subjects: 94
Study: 23093339

Group type: EXPERIMENTAL
Intervention: Smooth soup
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chunky soup
Number of subjects: 12

Group type: COMPARATOR
Intervention: Solid meal
Number of subjects: 12
Study: 20802322

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (10% solution of pentastarch)
Number of subjects: 262

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 262
Study: 18187744

Group type: EXPERIMENTAL
Intervention: Sildenafil (20, 40, or 80 mg three times daily)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 278
Study: 16439928

Group type: EXPERIMENTAL
Intervention: Life Skills Program (LSK)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory (SCT)
Number of subjects: 582

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Mothers in SCT group
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Mothers overall
Number of subjects: 582
Study: 15153584

Group type: EXPERIMENTAL
Intervention: Insole with dome pad design
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Insole with bar pad design
Number of subjects: 10

Group type: COMPARATOR
Intervention: Shoe-only control condition
Number of subjects: 10
Study: 11781759

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance subjects (n=322)
Number of subjects: 644

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Baseline waist-hip ratio (WHR)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Post-load 2 h plasma glucose
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: High baseline waist circumference or WHR (>= median)
Number of subjects: 644

Group type: COMPARATOR
Intervention: Low waist circumference (< median)
Number of subjects: 644
Study: 9407981

Group type: EXPERIMENTAL
Intervention: Fistulotomy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Incision and drainage (Control)
Number of subjects: 52
Study: 8352673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride (20 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride (0.1 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Drug-treated group (overall)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall (specific patients)
Number of subjects: 16
Study: 3602599

Group type: EXPERIMENTAL
Intervention: Ambroxol (30 mg tablet 3 times/day for adults; 9 mg syrup 4 times/day for children)
Number of subjects: 435

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 435
Study: 31272404

Group type: EXPERIMENTAL
Intervention: Parent-led strategies informed by behavioral economics implemented in 6 weekly cooking skills classes
Number of subjects: 103

Group type: COMPARATOR
Intervention: Vegetable cooking skills classes alone (Control)
Number of subjects: 103
Study: 28836285

Group type: EXPERIMENTAL
Intervention: Oral hygiene instruction (OHI), scaling and root debridement (n = 11)
Number of subjects: 18

Group type: COMPARATOR
Intervention: OHI alone (Control group, n = 7)
Number of subjects: 18
Study: 26024110

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 23323608

Group type: EXPERIMENTAL
Intervention: Sander bite-jumping appliance (BJA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 46
Study: 21136011

Group type: EXPERIMENTAL
Intervention: edoxaban 30 mg qd
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: edoxaban 60 mg qd
Number of subjects: 235

Group type: COMPARATOR
Intervention: warfarin (dose adjusted to INR of 2-3)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 235
Study: 20301881

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 30
Study: 17875844

Group type: EXPERIMENTAL
Intervention: Wide excision margins
Number of subjects: 3313

Group type: COMPARATOR
Intervention: Narrow excision margins
Number of subjects: 3313
Study: 15138774

Group type: EXPERIMENTAL
Intervention: Subvastus approach
Number of subjects: 52

Group type: COMPARATOR
Intervention: Parapatellar approach
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 11297483

Group type: EXPERIMENTAL
Intervention: Presenting visual acuity worse than 6/60 in both eyes
Number of subjects: 4284

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity worse than 6/60 in both eyes
Number of subjects: 4284

Group type: EXPERIMENTAL
Intervention: Cataract as the principal cause of blindness
Number of subjects: 4284

Group type: EXPERIMENTAL
Intervention: Uncorrected aphakia and other refractive error
Number of subjects: 4284

Group type: EXPERIMENTAL
Intervention: Cataract surgery prevalence
Number of subjects: 4284

Group type: EXPERIMENTAL
Intervention: Surgical coverage for cataract blind
Number of subjects: 4284
Study: 9669432

Group type: EXPERIMENTAL
Intervention: Acetate Dialysis (AD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Bicarbonate Dialysis (BD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Acetate-Free Biofiltration (AFB)
Number of subjects: 5
Study: 8145632

Group type: EXPERIMENTAL
Intervention: Computer-based interview
Number of subjects: 294

Group type: COMPARATOR
Intervention: Standard American Red Cross procedures (written questionnaires and face-to-face interviews)
Number of subjects: 294
Study: 3206202

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel (1% digluconate) applied in a custom tray for the mandibular arch, 10 min daily for 14 days with oral hygiene measures (toothbrush, toothpaste, dental floss)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chlorhexidine gel (1% digluconate) applied in a custom tray for the mandibular arch, 10 min daily for 14 days without oral hygiene measures
Number of subjects: 12
Study: 30143705

Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (usual sodium intake)
Number of subjects: 64
Study: 27044574

Group type: EXPERIMENTAL
Intervention: Quilting suture
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional closure with drainage
Number of subjects: 320
Study: 25831645

Group type: EXPERIMENTAL
Intervention: Serum 25‐hydroxy vitamin D levels in cases
Number of subjects: 169

Group type: COMPARATOR
Intervention: Serum 25‐hydroxy vitamin D levels in controls
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Parathormone and calcium levels in cases
Number of subjects: 169

Group type: COMPARATOR
Intervention: Parathormone and calcium levels in controls
Number of subjects: 169
Study: 23311969

Group type: EXPERIMENTAL
Intervention: Guided self-help intervention for parents of children with cancer
Number of subjects: 0
Study: 21391414

Group type: EXPERIMENTAL
Intervention: Cognitive reframing (CR) coping strategies
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Direct assistance (DA) coping strategies
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Existential well-being
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Specific coping strategies related to DSED
Number of subjects: 45
Study: 18430174

Group type: EXPERIMENTAL
Intervention: Quilting sutures
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no quilting sutures)
Number of subjects: 59
Study: 15723742

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (237 mL/d of 4 or 8 kJ/mL) for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 12828863

Group type: EXPERIMENTAL
Intervention: Soluble ICAM-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 0
Study: 11110008

Group type: EXPERIMENTAL
Intervention: Citalopram (active drug)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 222
Study: 8665186

Group type: EXPERIMENTAL
Intervention: 1-hexylcarbamoyl-5-fluorouracil (HCFU)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no HCFU)
Number of subjects: 67
Study: 2005733

Group type: EXPERIMENTAL
Intervention: 84 g of oatmeal
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 56 g of oat bran
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 84 g of oat bran
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 56 g of oatmeal
Number of subjects: 156

Group type: COMPARATOR
Intervention: 28 g of farina (beta-glucan control)
Number of subjects: 156
Study: 6824299

Group type: EXPERIMENTAL
Intervention: Subcutaneous bupivacaine injection around the wound
Number of subjects: 0
Study: 30237505

Group type: EXPERIMENTAL
Intervention: Resveratrol 500 mg/day
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Resveratrol 40 mg/day
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 26773778

Group type: EXPERIMENTAL
Intervention: Purified limonin glucoside (LG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 24448847

Group type: EXPERIMENTAL
Intervention: Facebook application for smoking cessation with various components (expanded content, proactive contact, active and passive sharing, use by non-smoker supporters)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference group (baseline R0)
Number of subjects: 0
Study: 21527434

Group type: EXPERIMENTAL
Intervention: Intervention Package B
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intervention Package A
Number of subjects: 14
Study: 20534325

Group type: EXPERIMENTAL
Intervention: L-carnitine-supplemented (10 mg/[kg d])
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (LCNS)
Number of subjects: 25
Study: 18723821

Group type: EXPERIMENTAL
Intervention: Case-based/problem-based (CB/PB) teaching method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lecture-based (LB) teaching method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both teaching methods
Number of subjects: 0
Study: 15863374

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (20 microg type 6, 40 microg type 11, 40 microg type 16, and 20 microg type 18) administered at day 1, month 2, and month 6.
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo preparations (two types).
Number of subjects: 277
Study: 12787419

Group type: EXPERIMENTAL
Intervention: Flow group (Qa <600 mL/min or clinical criteria)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Stenosis group (stenosis >50% or clinical criteria)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (clinical criteria)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Flow group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Stenosis group
Number of subjects: 101
Study: 10540051

Group type: EXPERIMENTAL
Intervention: 100 U of Botox (Allergan)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 250 U of Dysport (Ipsen)
Number of subjects: 78
Study: 8717471

Group type: EXPERIMENTAL
Intervention: Casodex (bicalutamide, 50 mg once daily) plus LHRH analogue (Zoladex 3.6 mg every 28 days or leuprolide 7.5 mg every 28 days)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Flutamide (250 mg three times daily) plus LHRH analogue (Zoladex 3.6 mg every 28 days or leuprolide 7.5 mg every 28 days)
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Casodex (bicalutamide, 50 mg once daily) plus LHRH analogue
Number of subjects: 813

Group type: COMPARATOR
Intervention: Flutamide (250 mg three times daily) plus LHRH analogue
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Casodex plus LHRH analogue
Number of subjects: 813
Study: 1648598

Group type: EXPERIMENTAL
Intervention: Cyclic-alternating treatment with ifosfamide/etoposide (IE), cyclophosphamide, doxorubicin, and vincristine (CAV)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Response-oriented treatment with IE therapy up to maximal response and subsequently an immediate switch to CAV
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Limited-stage disease (LD) patients with cyclic-alternating treatment
Number of subjects: 321

Group type: COMPARATOR
Intervention: Limited-stage disease (LD) patients with response-oriented treatment
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Extensive-stage disease (ED) patients with cyclic-alternating treatment
Number of subjects: 321

Group type: COMPARATOR
Intervention: Extensive-stage disease (ED) patients with response-oriented treatment
Number of subjects: 321